Multiparametric Magnetic Resonance Imaging (MRI) and MRI–Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen

European Urology

Volumn 70, Issue 5, 2016, Pages 846-853

  Radtke, Jan P ^a,b   Schwab, Constantin ^a   Wolf, Maya B ^b   Freitag, Martin T ^b   Alt, Celine D ^c   Kesch, Claudia ^a   Popeneciu, Ionel V ^a   Huettenbrink, Clemens ^a   Gasch, Claudia ^a   Klein, Tilman ^a   Bonekamp, David ^b   Duensing, Stefan ^a   Roth, Wilfried ^a   Schueler, Svenja ^a   Stock, Christian ^a   Schlemmer, Heinz Peter ^b   Roethke, Matthias ^b   Hohenfellner, Markus ^a   Hadaschik, Boris A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Biopsy; Cancer volume; Image fusion; Index tumor; Magnetic resonance imaging; Predictive values; Prostate cancer; Radical prostatectomy; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FUSION TARGETED BIOPSY; GENERAL ANESTHESIA; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE IMAGING REPORTING AND DATA SYSTEM SCORE; PROSTATECTOMY; RADIOLOGIST; RECTUM BIOPSY; RETROSPECTIVE STUDY; SATURATION BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY; TUMOR VOLUME; CANCER GRADING; CANCER STAGING; DIAGNOSTIC IMAGING; DIMENSIONAL MEASUREMENT ACCURACY; GERMANY; IMAGE GUIDED BIOPSY; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTATE; PROSTATE TUMOR;

AGED; ANESTHESIA, GENERAL; DIMENSIONAL MEASUREMENT ACCURACY; GERMANY; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR BURDEN; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84955318970     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.12.052     Document Type: Article

References (30)

1. [1] Siddiqui, M.M., Rais-Bahrami, S., Turkbey, B., et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313 (2015), 390–397.
2. [2] Panebianco, V., Barchetti, F., Sciarra, A., et al. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol Semin Orig Investig 33 (2015), 17e1–17e7.
3. [3] Barentsz, J.O., Richenberg, J., Clements, R., et al. ESUR prostate MR guidelines 2012. Eur Radiol 22 (2012), 746–757.
4. [4] Prostate Imaging Reporting and Data System (PI-RADS). American College of Radiology Web site. http://www.acr.org/Quality-Safety/Resources/PIRADS. Accessed July 2015.
5. [5] Rastinehad, A.R., Turkbey, B., Salami, S.S., et al. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J Urol 191 (2013), 1749–1754.
6. [6] Le, J.D., Stephenson, S., Brugger, M., et al. MRI-ultrasound fusion biopsy for prediction of final prostate pathology. J Urol 192 (2014), 1367–1373.
7. [7] Radtke, J.P., Kuru, T.H., Boxler, S., et al. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193 (2015), 87–94.
8. [8] Baco, E., Rud, E., Eri, L.M., et al. randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 69 (2016), 149–156.
9. [9] Onik, G., Miessau, M., Bostwick, D.G., Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol 27 (2009), 4321–4326.
10. [10] Moore, C.M., Robertson, N.L., Arsanious, N., et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63 (2013), 125–140.
11. [11] Rosenkrantz, A.B., Deng, F.M., Kim, S., et al. Prostate cancer: multiparametric MRI for index lesion localization–a multiple-reader study. AJR Am J Roentgenol 199 (2012), 830–837.
12. [12] Turkbey, B., Pinto, P.A., Mani, H., et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation. Radiology 255 (2010), 89–99.
13. [13] Baco, E., Ukimura, O., Rud, E., et al. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67 (2015), 787–794.
14. [14] Delongchamps, N.B., Lefèvre, A., Bouazza, N., Beuvon, F., Legman, P., Cornud, F., Detection of significant prostate cancer with magnetic resonance targeted biopsies–should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?. J Urol, 2014, 1198–1204.
15. [15] Le, J.D., Tan, N., Shkolyar, E., et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67 (2015), 569–576.
16. [16] Wolters, T., Roobol, M.J., van Leeuwen, P.J., et al. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185 (2011), 121–125.
17. [17] Kuru, T.H., Wadhwa, K., Chang, R.T., et al. Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. BJU Int 112 (2013), 568–577.
18. [18] Hadaschik, B., Kuru, T.H., Tulea, C., et al. A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol 186 (2011), 2214–2220.
19. [19] van der Kwast, T.H., Amin, M.B., Billis, A., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24 (2011), 16–25.
20. [20] Schmid, H.P., McNeal, J.E., An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16 (1992), 184–191.
21. [21] Tango, T., Equivalence test and confidence interval for the difference in proportions for the paired-sample design. Stat Med 17 (1998), 891–908.
22. [22] Dickinson, L., Ahmed, H.U., Allen, C., et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59 (2011), 477–494.
23. [23] Bossuyt, P.M., Reitsma, J.B., Bruns, D.E., et al. Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology 226 (2003), 24–28.
24. [24] Moore, C.M., Kasivisvanathan, V., Eggener, S., et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64 (2013), 544–552.
25. [25] Ukimura, O., Desai, M.M., Palmer, S., et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 187 (2012), 1080–1086.
26. [26] Le Nobin, J., Rosenkrantz, A.B., Villers, A., et al. Image guided focal therapy of MRI-visible prostate cancer: defining a 3D treatment margin based on MRI-histology co-registration analysis. J Urol 194 (2015), 364–370.
27. [27] Roobol, M.J., van Vugt, H., Loeb, S., et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol 61 (2012), 577–583.
28. [28] Meng, X., Rosenkrantz, A.B., Mendhiratta, N., et al. Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion–targeted prostate biopsy outcomes. Eur Urol 69 (2016), 512–517.
29. [29] Pokorny, M.R., de Rooij, M., Duncan, E., et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66 (2014), 22–29.
30. [30] Valerio, M., Donaldson, I., Emberton, M., et al. Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68 (2015), 8–19.